Business · 17/11/20261 min read
Opinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: EMA/PE/0000258486
Summary
Opinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: EMA/PE/0000258486